DRUG · Unmapped registry intervention
Antibiotics
Find medicine records ·
Find other trials using this name
Clinical trial
Fecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
NCT05502913
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
OTHER · Unmapped registry intervention
FMT (Fecal Microbiota Transplantation)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedFecal Microbiota Transplantation With Immune Checkpoint Inhibitors in Lung Cancer
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Metastatic Lung Cancerunresolved
Interventions
Sponsors & collaborators
Soroka University Medical Centerlead sponsor
Biotax Labs LTDcollaborator
Israel Cancer Associationcollaborator
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT05502913 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.